Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
pharmacology & pharmacy (13) 13
animals (11) 11
histamine h2-receptor antagonist (11) 11
index medicus (10) 10
cimetidine (9) 9
male (9) 9
histamine h2 antagonists - pharmacology (7) 7
ranitidine (7) 7
rats (7) 7
drug interactions (6) 6
drug-interactions (6) 6
medicine & public health (6) 6
histamine h (5) 5
internal medicine (5) 5
pharmacology/toxicology (5) 5
pharmacotherapy (5) 5
receptor antagonist (5) 5
dose-response relationship, drug (4) 4
drug therapy (4) 4
famotidine (4) 4
female (4) 4
gastro-oesophageal-reflux (4) 4
gastrokinetics (4) 4
histamine h-2-receptor antagonist (4) 4
histamine h2 antagonists - therapeutic use (4) 4
histamine h2-receptor antagonists (4) 4
histamine-h2-receptor antagonist (4) 4
histamine-h2-receptor-antagonists (4) 4
lafutidine (4) 4
piperidines - pharmacology (4) 4
rats, sprague-dawley (4) 4
acetamides - pharmacology (3) 3
administration, oral (3) 3
anti-ulcer agents - pharmacology (3) 3
biochemistry & molecular biology (3) 3
chemistry, physical (3) 3
cimetidine - pharmacology (3) 3
complexes (3) 3
crystal-structure (3) 3
dosage and administration (3) 3
double-blind (3) 3
esomeprazole (3) 3
frg-8813 (3) 3
histamine (3) 3
histamine-h2-receptor antagonists (3) 3
histamine-h2-receptor-antagonists, drug interactio (3) 3
nonsteroidal antiinflammatory drugs (3) 3
omeprazole (3) 3
pharmacokinetics (3) 3
proton pump inhibitors (3) 3
proton-pump-inhibitors (3) 3
proton-pump-inhibitors, drug interactions (3) 3
pyridines - pharmacology (3) 3
research (3) 3
stomach ulcer - chemically induced (3) 3
stomach ulcer - drug therapy (3) 3
stomach ulcer - prevention & control (3) 3
acid (2) 2
adult (2) 2
aged (2) 2
analysis (2) 2
antacids (2) 2
antacids, therapeutic use (2) 2
anti-ulcer agents - administration & dosage (2) 2
anti-ulcer agents - adverse effects (2) 2
anti-ulcer agents - therapeutic use (2) 2
antiretrovirals, drug interactions (2) 2
c10h16n6s (2) 2
capsaicin - pharmacology (2) 2
cattle (2) 2
chemiluminescence (2) 2
chemistry, analytical (2) 2
children (2) 2
conformation (2) 2
dermatology (2) 2
diagnosis (2) 2
disease (2) 2
dogs (2) 2
domperidone (2) 2
enzyme inhibitors - pharmacology (2) 2
famotidine - pharmacology (2) 2
food (2) 2
gastric acid - secretion (2) 2
gastric mucosa - pathology (2) 2
gastric-secretion (2) 2
gastro-oesophageal-reflux, treatment (2) 2
gastroesophageal reflux (2) 2
gastroesophageal reflux - drug therapy (2) 2
gastrokinetics, therapeutic use (2) 2
gene-related peptide (2) 2
h-1-nmr (2) 2
h-2 receptors (2) 2
h-2-receptor antagonists (2) 2
histamine h2 antagonists - chemistry (2) 2
histamine-h2-receptor-antagonists, therapeutic use (2) 2
human plasma (2) 2
hydrogen (2) 2
in-vitro (2) 2
inhibition (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral Drugs
by Kakuda, Thomas N and Schöller-Gyüre, Monika and Hoetelmans, Richard M. W
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text High Concomitant Use of Interacting Drugs and Low Use of Gastroprotective Drugs among NSAID Users in an Unselected Elderly Population
: A Nationwide Register-Based Study
by Ljung, Rickard and Lu, Yunxia and Lagergren, Jesper
Drugs & Aging, ISSN 1170-229X, 6/2011, Volume 28, Issue 6, pp. 469 - 476
Background: NSAIDs are commonly used in the elderly and carry significant risks of adverse events when used concomitantly with potentially interacting drugs.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Drug-interactions | Proton-pump-inhibitors, therapeutic use | Misoprostol, therapeutic use | Nonsteroidal-anti-inflammatories, drug interactions | Elderly | Histamine-H2-receptor-antagonists, therapeutic use | PREVENTION | PHARMACOLOGY & PHARMACY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ASSOCIATION | HEART-FAILURE | GERIATRICS & GERONTOLOGY | Drug Prescriptions - statistics & numerical data | Sweden | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Drug Interactions | Humans | Aged, 80 and over | Female | Gastrointestinal Tract - drug effects | Male | Registries | Aged | Prevention | Complications and side effects | Drug interactions | Aged patients | Dosage and administration | Research | Nonsteroidal anti-inflammatory drugs | Drug therapy | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Different effects of proton pump inhibitors and famotidine on the clopidogrel metabolic activation by recombinant CYP2B6, CYP2C19 and CYP3A4
by Ohbuchi, Masato and Noguchi, Kiyoshi and Kawamura, Akio and Usui, Takashi
Xenobiotica, ISSN 0049-8254, 7/2012, Volume 42, Issue 7, pp. 633 - 640
Inhibitory potential of proton pump inhibitors (PPIs) and famotidine, an H2 receptor antagonist, on the metabolic activation of clopidogrel was evaluated using... 
pantoprazole | omeprazole | esomeprazole | lansoprazole | famotidine and histamine H | Clopidogrel | rabeprazole | receptor antagonist | Omeprazole | Pantoprazole | Esomeprazole | Famotidine and histamine H2-receptor antagonist | Rabeprazole | Lansoprazole | GENETIC-POLYMORPHISM | DIAZEPAM | DRUG-INTERACTIONS | HUMAN CYTOCHROME-P450 | famotidine and histamine H-2-receptor antagonist | S-MEPHENYTOIN 4'-HYDROXYLATION | IN-VITRO | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | TOXICOLOGY | ANTIPLATELET ACTION | ACTIVE METABOLITE | Recombinant Proteins - metabolism | Oxidoreductases, N-Demethylating - genetics | Proton Pump Inhibitors - pharmacology | Ticlopidine - pharmacology | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Recombinant Proteins - genetics | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Drug Interactions | Cytochrome P-450 CYP3A - genetics | Cytochrome P-450 CYP2C19 | Cytochrome P-450 CYP3A - metabolism | Biotransformation | Famotidine - pharmacology | Oxidoreductases, N-Demethylating - metabolism | Cytochrome P-450 CYP2B6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects
by Li, Shihong and Xu, Mingzhen and Li, Huqun and Du, Juan and Li, Weiyong
Advances in Therapy, ISSN 0741-238X, 10/2016, Volume 33, Issue 10, pp. 1704 - 1714
The aim of this study was to evaluate the pharmacokinetics (PK) of single and multiple doses of oral lafutidine tablets and the effect of food on the PK... 
Rheumatology | Internal Medicine | Oncology | Gastritis | Helicobacter pylori infection | Medicine & Public Health | Gastric ulcers | Gastroenterology | Healthy subjects | Lafutidine tablet | Safety | Cardiology | Pharmacology/Toxicology | Pharmacokinetics | Endocrinology | Food | MEDICINE, RESEARCH & EXPERIMENTAL | HUMAN PLASMA | EFFICACY | RATS | HISTAMINE-H2-RECEPTOR ANTAGONIST | FRG-8813 | FAMOTIDINE | PHARMACOLOGY & PHARMACY | Tablets | Area Under Curve | Humans | Pyridines - pharmacokinetics | Male | Healthy Volunteers | Anti-Ulcer Agents - pharmacokinetics | Dose-Response Relationship, Drug | Tandem Mass Spectrometry | Pyridines - adverse effects | Acetamides - adverse effects | Adult | Female | Piperidines - pharmacokinetics | Piperidines - administration & dosage | Pyridines - administration & dosage | Acetamides - pharmacokinetics | Administration, Oral | Food-Drug Interactions | Anti-Ulcer Agents - adverse effects | Stomach Ulcer - drug therapy | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | Asian Continental Ancestry Group | Piperidines - adverse effects | Drug Monitoring | Acetamides - administration & dosage | Helicobacter infections | Analysis | Liquid chromatography
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Proton pump inhibitors (PPIs) and histamine H2-receptor antagonists can reduce trough concentrations of atazanavir
by
Reactions, ISSN 0114-9954, 08/2005, Volume 1, Issue 1065, pp. 5 - 5
Drug-interactions | Atazanavir, drug interactions | Histamine-H2-receptor-antagonists, drug interactio | Proton-pump-inhibitors, drug interactions
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Use of heartburn medications in patients with HIV appears to be widespread
by
Reactions, ISSN 0114-9954, 11/2004, Volume 1, Issue 1029, pp. 5 - 5
Drug-interactions | HIV-infections, treatment | Histamine-H2-receptor-antagonists, drug interactio | Drug-utilisation | OTC-drugs | Antacids, drug interactions | Trial-result-clinical | Vertex-Pharmaceuticals | Heartburn, treatment | Antiretrovirals, drug interactions | Gastro-oesophageal-reflux, treatment | Proton-pump-inhibitors, drug interactions | Gastrointestinal-ulcer, treatment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Clinical pharmacokinetics of famotidine
by Echizen, H and Echizen, Hirotoshi and Ishizaki, Takashi and Ishizaki, T
Clinical Pharmacokinetics, ISSN 0312-5963, 1991, Volume 21, Issue 3, pp. 178 - 194
Famotidine is a potent histamine H-2-receptor antagonist widely used in the treatment and prevention of peptic ulcer disease. After intravenous administration... 
HEALTHY-SUBJECTS | HISTAMINE H2-RECEPTOR ANTAGONIST | ZOLLINGER-ELLISON SYNDROME | PHARMACOLOGY & PHARMACY | URINARY-EXCRETION KINETICS | THERAPEUTIC USE | GASTRIC-SECRETION | CRITICALLY ILL PATIENTS | PEPTIC-ULCER DISEASE | H-2-RECEPTOR ANTAGONISTS | RENAL-INSUFFICIENCY | Dose-Response Relationship, Drug | Drug Interactions | Disease | Hemofiltration | Humans | Famotidine - pharmacokinetics | Aging - metabolism | Renal Dialysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text H2-antagonist/alcohol interaction only minor
by
1994, Volume 1, Issue 503, 1
Drug-interactions | Reviews-on-treatment | Histamine-H2-receptor-antagonists, drug interactio
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Gastroprotective Activity of FRG-8813, a Novel Histamine H2-Receptor Antagonist, in Rats
by Onodera, Sadayoshi and Shibata, Masahiro and Tanaka, Masato and Inaba, Niro and Yamaura, Tetsuaki and Ohnishi, Haruo
The Japanese Journal of Pharmacology, ISSN 0021-5198, 1995, Volume 68, Issue 2, pp. 161 - 173
FRG-8813 ((±)-2-(furfurylsulfinyl)-N-[4-[4-(piperidinomethyl)-2-pyridyl]oxy-(Z)-2-butenyl]acetamide) is a novel histamine H2-receptor antagonist with gastric... 
Gastroprotection | FRG-8813 | Antiulcer drug | Capsaicin-sensitive nerve | Histamine H2-receptor antagonist | Histamine H | Gastroprotecting | receptor antagonist | Stomach Ulcer - chemically induced | Histamine H2 Antagonists - pharmacology | Gastrointestinal Motility - drug effects | Rats | Stomach Ulcer - pathology | Acetamides - pharmacology | Gastric Mucosa - pathology | Male | Rats, Sprague-Dawley | Animals | Drug Interactions | Piperidines - pharmacology | Anti-Ulcer Agents - pharmacology | Omeprazole - pharmacology | Pyridines - pharmacology | Stomach Ulcer - prevention & control
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Prevention of Gastric Ulcer Relapse Induced by Indomethacin in Rats by a Mutein of Basic Fibroblast Growth Factor
by Satoh, Hiroshi and Asano, Shoichi and Maeda, Rika and Murakami, Izumi and Inada, Ikuko and Sato, Fumihiko and Shino, Akio
The Japanese Journal of Pharmacology, ISSN 0021-5198, 1997, Volume 73, Issue 3, pp. 229 - 241
We found indomethacin aggravates healed gastric ulcers (ulcer relapse)in rats. In the present study, we examined the effects of human basic fibroblast growth... 
TGP-580 | Basic fibroblast growth factor (bFGF) | bFGF mutein CS23 | Histamine H2-receptor antagonist | Gastric ulcer relapse | receptor antagonist | Histamine H | DUODENAL-ULCER | ACETIC-ACID ULCER | basic fibroblast growth factor (bFGF) | MECHANISMS | gastric ulcer relapse | LEUKOCYTE | THERAPY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ANTI-INFLAMMATORY DRUGS | DISEASE | PHARMACOLOGY & PHARMACY | ERADICATION | HELICOBACTER-PYLORI | histamine H-2-receptor antagonist | Cimetidine - therapeutic use | Immunohistochemistry | Recombinant Proteins - therapeutic use | Recurrence | Histamine H2 Antagonists - pharmacology | Fibroblast Growth Factor 2 - chemistry | Humans | Male | Fibroblast Growth Factors - analogs & derivatives | Indomethacin - administration & dosage | Histamine H2 Antagonists - administration & dosage | Drug Interactions | Acetic Acid - toxicity | Fibroblast Growth Factors - administration & dosage | Injections, Subcutaneous | Anti-Ulcer Agents - pharmacology | Cimetidine - administration & dosage | Stomach - drug effects | Ranitidine - pharmacology | Wound Healing - drug effects | Stomach Ulcer - prevention & control | Disease Models, Animal | Fibroblast Growth Factors - therapeutic use | Ranitidine - therapeutic use | Stomach Ulcer - chemically induced | Anti-Ulcer Agents - therapeutic use | Stomach - pathology | Administration, Oral | Stomach Ulcer - drug therapy | Acetic Acid - administration & dosage | Rats | Fibroblast Growth Factors - pharmacology | Recombinant Proteins - pharmacology | Histamine H2 Antagonists - therapeutic use | Rats, Sprague-Dawley | Anti-Inflammatory Agents, Non-Steroidal - toxicity | Recombinant Proteins - administration & dosage | Anti-Ulcer Agents - administration & dosage | Animals | Stomach - enzymology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Cimetidine - pharmacology | Gastric Acid - metabolism | Ranitidine - administration & dosage | Indomethacin - toxicity | Peroxidase - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Pd(II)- and Pt(II)-cimetidine complexes. Crystal structure of trans-[Pt(N,S-cimetidine)(2)]Cl-2 center dot 12H(2)O
by Onoa, GB and Moreno, V and Freisinger, E and Lippert, B
JOURNAL OF INORGANIC BIOCHEMISTRY, ISSN 0162-0134, 04/2002, Volume 89, Issue 3-4, pp. 237 - 247
The influence of cimetidine on patients under cisplatin treatment for cancer is controversial. It has moderate or no effects on several types of cancer and its... 
DRUG CIMETIDINE | BIOCHEMISTRY & MOLECULAR BIOLOGY | Pt-cimetidine molecular structure | HISTAMINE H2-RECEPTOR ANTAGONIST | X-RAY STRUCTURE | IONS | Pt-cimetidine complex | TETRAZOLIUM | DNA-cimetidine complex interaction | CHEMISTRY, INORGANIC & NUCLEAR | Pt antitumor complexes | COPPER(II) COMPLEXES | PT(II) | PLATINUM(II) | Pd-cimetidine complex | METAL-COMPLEXES | RANITIDINE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins
by Fukushima, Kazuhiro and Aoi, Yoko and Kato, Shinichi and Takeuchi, Koji
World Journal of Gastroenterology, ISSN 1007-9327, 05/2006, Volume 12, Issue 18, pp. 3031 - 3037
AIM: Lafutidine, a histamine H-2 receptor antagonist, exhibits gastro-protective action mediated by capsaicin-sensitive afferent neurons (CSN). We compared the... 
Lafutidine | A histamine H | Prostaglandin | Capsaicin-sensitive afferent neuron | Gastric protection | TRPV1 | receptor antagonist | HISTAMINE H-2-RECEPTOR ANTAGONIST | GENE-RELATED PEPTIDE | prostaglandin | afferent neuron | RECEPTOR | MUCOSAL BLOOD-FLOW | a histamine H-2-receptor antagonist | HCO3-SECRETION | lafutidine | RAT STOMACH | gastric protection | capsaicin-sensitive | ION-CHANNEL | CYTOPROTECTION | MICE | SENSORY NERVES | GASTROENTEROLOGY & HEPATOLOGY | Dinoprostone - analysis | Stomach - chemistry | Capsaicin - pharmacology | Histamine H2 Antagonists - pharmacology | Humans | Stomach Diseases - chemically induced | Acetamides - pharmacology | Gastric Mucosa - pathology | Male | Stomach Diseases - pathology | Calcium - analysis | 6-Ketoprostaglandin F1 alpha - analysis | Dose-Response Relationship, Drug | Piperidines - pharmacology | TRPV Cation Channels - antagonists & inhibitors | Receptors, Epoprostenol - physiology | Stomach Diseases - prevention & control | Stomach - drug effects | Gastric Mucosa - chemistry | NG-Nitroarginine Methyl Ester - pharmacology | Neurons, Afferent - drug effects | TRPV Cation Channels - physiology | Mice, Inbred C57BL | Rats | Capsaicin - analogs & derivatives | Neurons, Afferent - physiology | Rats, Sprague-Dawley | Indomethacin - pharmacology | Mice, Knockout | Prostaglandins - physiology | Receptors, Epoprostenol - genetics | Animals | Mice | Pyridines - pharmacology | A histamine H2-receptor antagonist | Basic Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Gastro-Oesophageal Reflux Disease
: Beyond Proton Pump Inhibitor Therapy
by Hershcovici, Tiberiu and Fass, Ronnie
Drugs, ISSN 0012-6667, 12/2011, Volume 71, Issue 18, pp. 2381 - 2389
Gastro-oesophageal reflux disease (GORD or GERD) is a very common disorder, and advancement in drug development over the years has markedly improved disease... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Proton-pump-inhibitors | Gastro-oesophageal-reflux | Histamine-H2-receptor-antagonists | Gastrokinetics | ESOPHAGEAL SPHINCTER RELAXATION | GERD | AGONIST BACLOFEN | CLINICAL-TRIAL | DOUBLE-BLIND | ACID EXPOSURE | RISK | PHARMACOLOGY & PHARMACY | RADIOFREQUENCY ENERGY DELIVERY | SYMPTOMS | TOXICOLOGY | RANITIDINE | Anti-Ulcer Agents - therapeutic use | Proton Pump Inhibitors - adverse effects | GABA-B Receptor Agonists - therapeutic use | Humans | Anti-Ulcer Agents - adverse effects | Endoscopy - methods | Histamine H2 Antagonists - adverse effects | Treatment Outcome | Proton Pump Inhibitors - therapeutic use | Histamine H2 Antagonists - therapeutic use | Randomized Controlled Trials as Topic | Antacids - therapeutic use | Time Factors | Complementary Therapies - methods | Gastroesophageal Reflux - drug therapy | Gastroesophageal reflux | Fundoplication | Proton pump inhibitors | Research | Drug therapy | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Studies of DNA-binding properties of lafutidine as adjuvant anticancer agent to calf thymus DNA using multi-spectroscopic approaches, NMR relaxation data, molecular docking and dynamical simulation
by Yang, Hongqin and Tang, Bin and Tang, Peixiao and Huang, Yanmei and He, Jiawei and Li, Hui and Li, Shanshan
International Journal of Biological Macromolecules, ISSN 0141-8130, 06/2017, Volume 99, pp. 79 - 87
The interactions between lafutidine (LAF) and calf thymus DNA (ctDNA) have been investigated both experimentally and theoretically. UV–vis absorption studies... 
Lafutidine | Calf thymus DNA | Groove binding | DRUG | POLYMER SCIENCE | ACID | MINOR-GROOVE BINDER | HUMAN SERUM-ALBUMIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOUBLE-STRANDED DNA | CTDNA | IN-VITRO | HISTAMINE-H2-RECEPTOR ANTAGONIST | PARAMETERIZATION | FORCE-FIELD | CHEMISTRY, APPLIED | Piperidines - chemistry | Magnetic Resonance Spectroscopy | Piperidines - metabolism | Pyridines - chemistry | DNA - metabolism | Antineoplastic Agents - chemistry | Molecular Dynamics Simulation | Antineoplastic Agents - metabolism | Acetamides - metabolism | Thermodynamics | DNA - chemistry | Acetamides - chemistry | Animals | Pyridines - metabolism | Cattle | Molecular Docking Simulation | Nucleic Acid Conformation | Antimitotic agents | Hydrogen | Analysis | DNA | Genetic research | Nuclear magnetic resonance | Antineoplastic agents | Fluorescence spectroscopy | Molecular dynamics | Fluorescence | Potassium iodide
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Histamine, histamine H2-receptor antagonists, gastric acid secretion and ulcers: an overview
by Pattichis, K and Pattichis, Katerina and Louca, L.L and Louca, Louis L
Drug metabolism and drug interactions, ISSN 0792-5077, 1995, Volume 12, Issue 1, pp. 1 - 36
Histamine, a biogenic amine, is involved in allergic reactions and asthma. The involvement of histamine in peptide ulcers is reviewed here. The discovery,... 
gastric acid secretion | histamine H2-receptor antagonists | histamine | peptic ulcers | histamine H2-receptors | Gastric Acid - secretion | Animals | Histamine - physiology | Histamine H2 Antagonists - pharmacology | Humans | Stomach Ulcer - drug therapy | Histamine H2 Antagonists - therapeutic use | Stomach Ulcer - physiopathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text TIME-DEPENDENT INTERACTION OF A NEW H-2-RECEPTOR ANTAGONIST, IT-066, WITH THE RECEPTOR IN THE ATRIA OF GUINEA-PIG
by MURAMATSU, M and HIROSEKIJIMA, H and AIHARA, H and OTOMO, S
JAPANESE JOURNAL OF PHARMACOLOGY, ISSN 0021-5198, 09/1991, Volume 57, Issue 1, pp. 13 - 23
3-Amino-4-[4-[4-(1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1,2-dione hydrochloride (IT-066) showed a highly potent and long lasting... 
DRUG RECEPTORS | INHIBITION | DOGS | HISTAMINE H2-RECEPTOR ANTAGONISTS | PHARMACOLOGY & PHARMACY | GASTRIC-ACID SECRETION | YM-11170
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Consider the benefits and limitations of the available options when treating gastro-oesophageal reflux disease
by
Drugs & Therapy Perspectives, ISSN 1172-0360, 7/2012, Volume 28, Issue 7, pp. 14 - 16
  Proton pump inhibitors (PPIs) remain the cornerstone of gastro-oesophageal reflux disease (GORD) management. However, the limitations of PPIs and emerging... 
Pharmacotherapy | Pharmacy | Domperidone | Proton-pump-inhibitors | Surgery | Baclofen | Therapeutic-procedures | Acupuncture | Gastro-oesophageal-reflux | Histamine-H2-receptor-antagonists | Metoclopramide | Gastrokinetics | Gastroesophageal reflux | Proton pump inhibitors | Dosage and administration | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Electrochemical oxidation of ranitidine at poly(dopamine) modified carbon paste electrode: Its voltammetric determination in pharmaceutical and biological samples based on the enhancement effect of anionic surfactant
by Talay Pınar, P and Yardım, Y and Şentürk, Z
Sensors & Actuators: B. Chemical, ISSN 0925-4005, 11/2018, Volume 273, pp. 1463 - 1473
The preparation and characterization of a carbon paste electrode modified with poly(dopamine) as well as its novel application for the electrochemical... 
Electrooxidation | Real samples | Ranitidine | Square-wave voltammetry | Sodium dodecyl sulphate | Carbon paste electrode | Poly(dopamine) | ELECTROCHEMISTRY | CHEMISTRY, ANALYTICAL | CHEMILUMINESCENCE | HYDROCHLORIDE | H-2-RECEPTOR ANTAGONIST | NANOPARTICLES | INSTRUMENTS & INSTRUMENTATION | FORMULATIONS | URINE | CAPILLARY-ELECTROPHORESIS | HISTAMINE-H2-RECEPTOR ANTAGONISTS | METRONIDAZOLE | POLYDOPAMINE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Homology Modeling and Antagonist Binding Site Study of the Human Histamine H2 Receptor
by Zhang, J and Qi, T and Wei, J
MEDICINAL CHEMISTRY, ISSN 1573-4064, 11/2012, Volume 8, Issue 6, pp. 1084 - 1092
On the basis of the high resolution crystal structures of bovine rhodopsin, human beta2-adrenergic receptor and human A(2a) adenosine receptor,... 
MOLECULAR-DYNAMICS | 3D STRUCTURE | CHEMISTRY, MEDICINAL | CRYSTAL-STRUCTURE | DOCKING | Molecular dynamics | PROTEASE CLEAVAGE SITES | SUBCELLULAR-LOCALIZATION | HISTAMINE H2-RECEPTOR ANTAGONIST | Antagonists | Binding site | Molecular docking | SEQUENCE ALIGNMENT | Homology modeling | Human histamine H2 receptor | RECEPTORS | PROTEINS | Histamine H2 Antagonists - pharmacology | Receptors, Histamine H2 - chemistry | Humans | Receptors, Histamine H2 - genetics | Molecular Dynamics Simulation | Histamine H2 Antagonists - chemistry | Sequence Homology, Amino Acid | Thermodynamics | Histamine H2 Antagonists - metabolism | Animals | Hydrogen Bonding | Mutagenesis | Cattle | Drug Design | Protein Conformation | Binding Sites | Receptors, Histamine H2 - metabolism
Journal Article
Details down arrow
20. Full Text Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism
by Ichikawa, Takafumi and Ishihara, Kazuhiko and Saigenji, Katsunori and Hotta, Kyoko
British Journal of Pharmacology, ISSN 0007-1188, 11/1997, Volume 122, Issue 6, pp. 1230 - 1236
1 The structural requirements of the histamine H2‐receptor antagonist, roxatidine (2‐acetoxy‐N‐(3‐[m‐(1‐piperidinylmethyl)phenoxy]‐propyl)acetamide... 
histamine H2‐receptor antagonists | nitric oxide (NO) | Roxatidine | gastric mucin biosynthesis | organ culture | Gastric mucin biosynthesis | Histamine H | receptor antagonists | Nitric oxide (NO) | Organ culture | HISTAMINE H-2-RECEPTOR ANTAGONIST | ACID | PROTEIN | roxatidine | PHARMACOLOGICAL CHARACTERIZATION | MUCOSAL CELLS | AUTORADIOGRAPHIC LOCALIZATION | MUCUS SECRETION | BIOSYNTHESIS | PHARMACOLOGY & PHARMACY | histamine H-2-receptor antagonists | H-2 RECEPTORS | STOMACH | Free Radical Scavengers - pharmacology | Rats, Wistar | Histamine H2 Antagonists - pharmacology | Receptors, Histamine H2 - drug effects | Enzyme Inhibitors - pharmacology | Nitric Oxide Synthase - antagonists & inhibitors | Rats | Male | Nitric Oxide - physiology | Imidazoles - pharmacology | Gastric Mucosa - metabolism | Mucins - biosynthesis | Nitroarginine - pharmacology | Animals | Piperidines - pharmacology | Gastric Mucosa - drug effects | Benzoates - pharmacology | Ranitidine - pharmacology | Papers | histamine H2-receptor antagonists
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights